Dr. Jeffrey Almond began his career as an academic virologist studying influenza. Eventually Jeffrey started his own lab and began studying picornaviruses working on an oral polio vaccine strain.
Following twenty years in academics including major contributions in the eradication of polio worldwide, Jeffrey transitioned into a career in industry working on vaccine development at Sanofi Pasteur.
In March of 2013, Jeffrey was at the Society for General Microbiology's Spring conference to give the Colworth Prize Lecture awarded biennially for an outstanding contribution in an area of applied microbiology. Jeffrey's talk was titled: Vaccines R&D: challenges for the 21st century.
On this episode, Vincent Racaniello talks with Dr. Almond about the future of vaccines, his transition from academia to industry and his prize lecture.
